New Enterprise Associates 16 L.P. 13D and 13G filings for Black Diamond Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-13 7:09 pm Purchase | 2024-05-09 | 13D | Black Diamond Therapeutics, Inc. BDTX | New Enterprise Associates 16 L.P. | 4,546,947 8.100% | 1,098,190 (+31.84%) | Filing |